Independent variables | CHR (95% CI) | AHR (95% CI) |
---|---|---|
Age in years | ||
 15–24 | 1.00 | 1.00 |
 25–34 | 0.99 (0.43–2.27) | 0.70 (0.25–1.92) |
 35–44 | 1.51 (0.65–3.50) | 1.11 (0.37–3.31) |
 ≥ 45 | 2.29 (0.99–5.31) | 2.43 (0.81–7.31) |
Sex | ||
 Female | 1.00 | 1.00 |
 Male | 2.10 (1.35–3.27) | 2.40 (1.24–4.62)*** |
Education level | ||
 No education | 1.94 (0.96–3.90) | 0.68 (0.26–1.79) |
 Primary | 1.10 (0.48–2.52) | 0.59 (0.19–1.82) |
 Secondary & above | 1.00 | 1.00 |
Hemoglobin | ||
 Low | 5.73 (3.71–8.85) | 4.14 (2.18–7.86)*** |
 Normal | 1.00 | 1.00 |
Viral load | ||
 ≤ 1000 | 1.00 | 1.00 |
 > 1000 | 9.84 (5.78–16.73) | 6.70 (3.40–13.22)*** |
CD4 | ||
 ≤ 200 | 6.90 (3.87–12.31) | 1.71 (0.77–3.76) |
 201–350 | 0.89 (0.36–2.20) | 0.53 (0.16–1.76) |
 > 351 | 1.00 | 1.00 |
TB coinfection | ||
 Yes | 5.24 (3.04–9.05) | 3.71 (1.59-8.64)*** |
 No | 1.00 | 1.00 |
BMI in kg/m2 | ||
 ≥ 18.5 | 1.00 | 1.00 |
 15.5–18.4 | 1.88 (1.15–3.09) | 1.07 (0.51–2.22) |
 ≤ 15.4 | 2.43 (1.41–4.20) | 2.45 (1.17–5.10)*** |
WHO clinical stage | ||
 Stage I | 1.00 | 1.00 |
 Stage II | 3.92 (1.84–8.34) | 2.58 (0.94–7.07) |
 Stage III | 3.63 (1.82–7.24) | 3.31 (1.35–8.10)*** |
 Stage IV | 6.52 (3.46–12.30) | 5.64 (2.53–12.56)*** |
Functional status | ||
 Working | 1.00 | 1.00 |
 Ambulatory | 3.57 (2.04–6.23) | 1.04 (0.48–2.24) |
 Bedridden | 4.40 (2.70–7.18) | 0.93 (0.45–1.94) |
Adherence | ||
 Good | 1.00 | 1.00 |
 Fair | 0.27 (0.08–0.86) | 0.38 (0.08–1.70) |
 Poor | 1.37 (0.77–2.43) | 0.92 (0.40–2.09) |
Disclosure status | ||
 Yes | 1.00 | 1.00 |
 No | 1.43 (0.93–2.19) | 0.84 (0.45–1.58) |
OIs other than TB | ||
 Yes | 3.41 (2.16–5.39) | 1.19 (0.55–2.55) |
 No | 1.00 | 1.00 |
Occupation | ||
 Merchant | 1.00 | 1.00 |
 Daily laborer | 8.86 (2.15–36.54) | 5.57 (0.71–43.94) |
 Farmer | 5.97 (1.39–25.53) | 3.81 (0.45–32.01) |
 Housewife | 4.90 (1.12–21.44) | 5.74 (0.68–48.23) |
 Othersa | 2.62 (0.37–18.56) | 0.45 (0.02–9.14) |